10.80
price up icon1.41%   0.15
after-market 시간 외 거래: 10.85 0.05 +0.46%
loading
전일 마감가:
$10.65
열려 있는:
$10.73
하루 거래량:
348.77K
Relative Volume:
0.31
시가총액:
$830.88M
수익:
-
순이익/손실:
$-119.87M
주가수익비율:
-5.9669
EPS:
-1.81
순현금흐름:
$-109.90M
1주 성능:
+2.86%
1개월 성능:
+28.57%
6개월 성능:
+26.32%
1년 성능:
+43.62%
1일 변동 폭
Value
$10.60
$10.88
1주일 범위
Value
$9.80
$11.19
52주 변동 폭
Value
$3.8951
$14.67

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Name
명칭
Oric Pharmaceuticals Inc
Name
전화
(650) 388-5600
Name
주소
240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA
Name
직원
122
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
ORIC's Discussions on Twitter

ORIC을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ORIC
Oric Pharmaceuticals Inc
10.80 830.88M 0 -119.87M -109.90M -1.81
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.62 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.36 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
331.91 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
543.48 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.49 28.51B 3.81B -644.79M -669.77M -6.24

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-31 개시 Wells Fargo Overweight
2024-09-06 개시 Stifel Buy
2024-02-23 개시 Cantor Fitzgerald Overweight
2023-09-22 개시 Wedbush Outperform
2023-03-23 업그레이드 H.C. Wainwright Neutral → Buy
2023-03-21 업그레이드 Guggenheim Neutral → Buy
2023-03-16 업그레이드 Oppenheimer Perform → Outperform
2022-07-18 재개 Oppenheimer Perform
2022-04-04 업그레이드 Citigroup Neutral → Buy
2022-03-25 다운그레이드 H.C. Wainwright Buy → Neutral
2022-03-22 다운그레이드 Citigroup Buy → Neutral
2022-03-22 다운그레이드 Guggenheim Buy → Neutral
2022-03-22 다운그레이드 Oppenheimer Outperform → Perform
2021-07-06 업그레이드 Citigroup Neutral → Buy
2021-01-25 다운그레이드 Citigroup Buy → Neutral
2020-08-13 개시 Robert W. Baird Outperform
2020-08-06 업그레이드 Citigroup Neutral → Buy
2020-08-03 개시 H.C. Wainwright Buy
2020-05-19 개시 Citigroup Neutral
2020-05-19 개시 Guggenheim Buy
2020-05-19 개시 JP Morgan Overweight
2020-05-19 개시 Jefferies Buy
모두보기

Oric Pharmaceuticals Inc 주식(ORIC)의 최신 뉴스

pulisher
Jun 18, 2025

Oric Pharmaceuticals (NASDAQ:ORIC) Trading Down 3.4%Here's Why - MarketBeat

Jun 18, 2025
pulisher
Jun 16, 2025

(ORIC) Trading Report - news.stocktradersdaily.com

Jun 16, 2025
pulisher
Jun 15, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down Following Insider Selling - MarketBeat

Jun 15, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Has $223,000 Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

Research Analysts Issue Forecasts for ORIC FY2026 Earnings - MarketBeat

Jun 14, 2025
pulisher
Jun 14, 2025

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 2,976 Shares - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Oric Pharmaceuticals Elects Directors at Annual Meeting - TipRanks

Jun 13, 2025
pulisher
Jun 13, 2025

What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now? - sharewise

Jun 13, 2025
pulisher
Jun 13, 2025

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down After Insider Selling - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Dominic Piscitelli Sells 2,600 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

Bank of America Corp DE Acquires 28,570 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

Jun 12, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Trims Stock Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Brokers Issue Forecasts for ORIC FY2026 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Insider Sell: Dominic Piscitelli Sells Shares of ORIC Pharmaceuticals Inc (ORIC) - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of “Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of "Buy" from Analysts - MarketBeat

Jun 11, 2025
pulisher
Jun 10, 2025

Transcript : ORIC Pharmaceuticals, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - MarketScreener

Jun 10, 2025
pulisher
Jun 09, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap UpStill a Buy? - MarketBeat

Jun 09, 2025
pulisher
Jun 08, 2025

Two Sigma Investments LP Decreases Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

Jun 08, 2025
pulisher
Jun 08, 2025

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Acquired by Bank of America Corp DE - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up – Here’s What Happened - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News - GuruFocus

Jun 07, 2025
pulisher
Jun 07, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 7.6%Still a Buy? - MarketBeat

Jun 07, 2025
pulisher
Jun 07, 2025

ORIC® Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Updates - mx.advfn.com

Jun 07, 2025
pulisher
Jun 06, 2025

Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule - marketscreener.com

Jun 06, 2025
pulisher
Jun 06, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 06, 2025
pulisher
Jun 06, 2025

ORIC Pharmaceuticals Expands Oncology Team with 45,600 Equity Grants for New Clinical Specialists - Stock Titan

Jun 06, 2025
pulisher
Jun 06, 2025

ORIC Pharmaceuticals, Inc. announced that it has received $124.999983 million in funding from a group of investors - MarketScreener

Jun 06, 2025
pulisher
Jun 06, 2025

Cantor Fitzgerald Estimates ORIC FY2025 Earnings - MarketBeat

Jun 06, 2025
pulisher
Jun 06, 2025

Two Sigma Investments LP Decreases Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 3.5%What's Next? - MarketBeat

Jun 06, 2025
pulisher
Jun 04, 2025

Two Sigma Advisers LP Acquires 8,300 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Viking Invests $125 Million in ORIC Pharmaceuticals PIPE Financing - Global Legal Chronicle

Jun 03, 2025
pulisher
Jun 03, 2025

Wall Street Analysts Predict a 131.33% Upside in Oric Pharmaceuticals (ORIC): Here's What You Should Know - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap DownTime to Sell? - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

ORIC Pharmaceuticals (NASDAQ:ORIC) Sees Unusually-High Trading VolumeStill a Buy? - MarketBeat

Jun 03, 2025
pulisher
Jun 03, 2025

H.C. Wainwright maintains buy rating on ORIC Pharmaceuticals stock By Investing.com - Investing.com Nigeria

Jun 03, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Buys New Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Wedbush Reiterates Outperform Rating for ORIC Pharmaceuticals (NASDAQ:ORIC) - MarketBeat

Jun 03, 2025
pulisher
Jun 02, 2025

Oric Pharma Stock Hits 3-Month High On Promising Results In Prostate Cancer Trial - MSN

Jun 02, 2025
pulisher
Jun 02, 2025

Viking in PIPE Investment in ORIC Pharmaceuticals - Cleary Gottlieb

Jun 02, 2025

Oric Pharmaceuticals Inc (ORIC) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Oric Pharmaceuticals Inc 주식 (ORIC) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Piscitelli Dominic
Chief Financial Officer
Jun 24 '25
Sale
10.50
32,466
341,039
68,317
Piscitelli Dominic
Chief Financial Officer
Jun 23 '25
Sale
10.00
1,034
10,344
100,783
You Angie
Director
Jun 20 '25
Buy
9.39
26,597
249,669
26,597
You Angie
Director
Jun 23 '25
Buy
9.43
1,403
13,230
28,000
Piscitelli Dominic
Chief Financial Officer
Jun 12 '25
Sale
10.00
300
3,000
101,817
Piscitelli Dominic
Chief Financial Officer
Jun 11 '25
Sale
10.01
2,976
29,777
102,117
Piscitelli Dominic
Chief Financial Officer
Jun 10 '25
Sale
10.00
324
3,240
105,093
Piscitelli Dominic
Chief Financial Officer
Jun 06 '25
Sale
10.01
2,600
26,021
104,164
Piscitelli Dominic
Chief Financial Officer
Jun 09 '25
Sale
10.00
300
3,000
103,864
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
자본화:     |  볼륨(24시간):